Vote Scores

Home / Companies / Sartorius Stedim Biotech SA / 25 Mar 2025

Meeting · year to 30 June 2025130 filers reporting

Sartorius Stedim Biotech SA: meeting of 25 Mar 2025

Votes reported on Form N-PX, item by item

130 Form N-PX filers reported votes at the Sartorius Stedim Biotech SA meeting of 25 Mar 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

6 nominees; 72.0% of reported votes for; 70 filers withheld from or voted against at least one nominee.

1,141 vote records from 106 filers. 11 of the 105 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

82.1% for11.3% against6.6% other10.5% against management106 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

306 vote records from 42 filers. 0 of the 40 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

92.9% for0.0% against7.1% other0.0% against management42 filers82.8% for17.2% against17.1% against management12,148,041 reported shares
3

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

25 vote records from 8 filers. 7 of the 8 filers that marked the item either way voted against management.

12.5% for87.5% against87.5% against management8 filers0.0% for100.0% against100.0% against management597,171 reported shares, counted once per item in this group
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

2,031 vote records from 106 filers. 64 of the 105 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

32.1% for61.3% against6.6% other61.0% against management106 filers63.4% for36.6% against36.1% against management50,605,049 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

1,303 vote records from 107 filers. 5 of the 106 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

57.9% for4.7% against37.4% other4.7% against management107 filers78.5% for21.5% against21.5% against management32,103,786 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

687 vote records from 106 filers. 0 of the 105 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

96.2% for0.0% against3.8% other0.0% against management106 filers86.0% for14.0% against14.0% against management13,313,287 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

146 vote records from 13 filers. 0 of the 12 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

92.3% for0.0% against7.7% other0.0% against management13 filers99.9% for0.1% against0.1% against management1,222,698 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay
VanguardForFor
BlackRock and iSharesForFor
FidelityForNo report
DimensionalSplit or no voteNo report
State Street and SPDRAgainst *No report
American CenturyForNo report
Franklin TempletonForNo report
InvescoForNo report
EquitableForNo report
Charles SchwabForNo report
Nuveen and TIAAAgainst *No report
John Hancock and ManulifeForFor
Morgan Stanley, Eaton Vance and CalvertAgainst *No report
J.P. MorganForFor
Goldman SachsForNo report
WisdomTreeForNo report
PGIM and PrudentialForNo report
Jackson National fundsForFor
Northern Trust and FlexSharesForFor
T. Rowe PriceForNo report
ThriventForNo report
Lincoln FinancialAgainst *No report
VoyaForNo report
First TrustForFor
Russell InvestmentsForNo report
NationwideForNo report
Victory CapitalForNo report
Brighthouse FundsForFor
Columbia ThreadneedleSplit or no voteNo report
BNY MellonForNo report
PrincipalForNo report
Pacific Life fundsForNo report
TransamericaForNo report
AllianceBernsteinAgainst *No report
PIMCOForNo report
MassMutualForNo report
VanEckForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Sartorius Stedim Biotech SA meeting?

130 Form N-PX filers reported votes at the meeting of 25 Mar 2025. On say-on-pay, 0 of 40 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sartorius Stedim Biotech SA on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Sartorius Stedim Biotech SA

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sartorius Stedim Biotech SA with a meeting date within three days of 25 Mar 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.